Who owns AN2 Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ANTX from SEC Form 13F filings across 88 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 88 institutions disclosed 26.9M shares of AN2 Therapeutics, Inc. worth $143.2M — about 58.4% of shares outstanding; the largest disclosed holder is Vivo Capital, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
88
13F holders
$143.2M
value, 2026 filers
58.4%
of shares outstanding (26.9M sh)
25
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ANTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Vivo Capital, LLC | 3.2M | $16.8M | 1.8% | 6.8% | 0.0% |
| 2 | Commodore Capital LP | 2.9M | $15.6M | 1.2% | 6.4% | 0.0% |
| 3 | MILLENNIUM MANAGEMENT LLC | 2.5M | $13.2M | 0.0% | 5.4% | +6.8% |
| 4 | BlackRock, Inc. | 1.8M | $9.4M | 0.0% | 3.8% | +6.4% |
| 5 | Spruce Street Capital LP | 1.8M | $9.3M | 1.5% | 3.8% | +5.5% |
| 6 | ACORN CAPITAL ADVISORS, LLCNEW | 1.3M | $6.9M | 1.9% | 2.8% | new |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $6.6M | 0.0% | 2.7% | 0.0% |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.0M | $5.3M | 0.0% | 2.2% | 0.0% |
| 9 | CITADEL ADVISORS LLC | 984,080 | $5.2M | 0.0% | 2.1% | +3.4% |
| 10 | Boxer Capital Management, LLC | 944,035 | $5.0M | 0.4% | 2% | +26.0% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 684,122 | $3.6M | 0.0% | 1.5% | -2.0% |
| 12 | GOLDMAN SACHS GROUP INC | 634,655 | $3.4M | 0.0% | 1.4% | +621.7% |
| 13 | Tetragon Partners GP LtdNEW | 603,424 | $3.2M | 0.4% | 1.3% | new |
| 14 | SummitTX Capital, L.P.NEW | 597,793 | $3.2M | 0.1% | 1.3% | new |
| 15 | Sio Capital Management, LLC | 548,103 | $2.9M | 0.6% | 1.2% | +3.4% |
| 16 | AMERIPRISE FINANCIAL INC | 537,225 | $2.9M | 0.0% | 1.2% | 0.0% |
| 17 | Ally Bridge Group (NY) LLC | 526,315 | $2.8M | 3.7% | 1.1% | 0.0% |
| 18 | Woodline Partners LP | 447,420 | $2.4M | 0.0% | 1% | -2.7% |
| 19 | STATE STREET CORP | 444,468 | $2.4M | 0.0% | 1% | +42.6% |
| 20 | Stonepine Capital Management, LLC | 350,877 | $1.9M | 1.2% | 0.8% | -36.4% |
| 21 | Prosight Management, LP | 350,877 | $1.9M | 0.4% | 0.8% | -26.1% |
| 22 | Almitas Capital LLC | 349,068 | $1.9M | 0.4% | 0.8% | -76.2% |
| 23 | Balyasny Asset Management L.P. | 287,250 | $1.5M | 0.0% | 0.6% | -48.3% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 255,878 | $1.4M | 0.0% | 0.6% | +2412.3% |
| 25 | Seven Fleet Capital Management LP | 254,309 | $1.4M | 0.3% | 0.6% | +21.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.